MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


0026-895X/04/6505-1080-1091$20.00
Mol Pharmacol 65:1080-1091, 2004

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shafer, S. H.
Right arrow Articles by Williams, C. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shafer, S. H.
Right arrow Articles by Williams, C. L.

Elevated Rac1 Activity Changes the M3 Muscarinic Acetylcholine Receptor-Mediated Inhibition of Proliferation to Induction of Cell Death

Shulamith H. Shafer, and Carol L. Williams

Molecular Pharmacology Laboratory, Guthrie Research Institute, Sayre, Pennsylvania

Although muscarinic acetylcholine receptors (mAChRs) regulate proliferation in many cell types, the signaling pathways involved are unclear. The participation of the small GTPases Rac1 and RhoA in M3 mAChR-mediated inhibition of proliferation was investigated by activating M3 mAChRs stably transfected in Chinese hamster ovary cells stably coexpressing hemagglutinin (HA)-tagged wild-type or mutant Rac1 or RhoA proteins. Activation of M3 mAChRs activates both Rac1 and RhoA and inhibits cell proliferation in all cell lines tested. mAChR-mediated inhibition of proliferation is diminished in cells expressing dominant-negative HA-Rac1Asn17 (m3DNRac) but is enhanced in cells expressing HA-Rac1 (m3WTRac) or constitutively active HA-RacVal12 (m3CARac). The activation of mAChRs in m3WTRac and m3CARac cells also induces apoptosis. Expression of wild-type or mutant RhoA proteins does not alter mAChR-mediated inhibition of proliferation. mAChR-induced inhibition of proliferation is abrogated in all cell lines when G{alpha}q/11 signaling is terminated by transient expression of the COOH-terminal fragment of phospholipase C (PLC-{beta}1ct), the NH2-terminal fragment of G protein-coupled receptor kinase, or the regulator of G protein signaling 2. Pretreatment of all cells expressing wild-type or mutant Rac1 proteins with edelfosine, a phosphatidylinositol-specific PLC inhibitor, or Go 6976, which inhibits conventional protein kinase C (PKC) isoforms, diminishes the M3 mAChR's ability to inhibit proliferation. Our results identify G{alpha}q/11, PLC, and PKC as participants in the M3 mAChR-mediated inhibition of cell proliferation. These findings indicate that in the context of high Rac1 activity, but not RhoA activity, M3 mAChR-mediated activation of these participants triggers cell death.


Received September 25, 2003; accepted January 28, 2004

Address correspondence to: Carol L. Williams, Ph.D., Molecular Pharmacology Laboratory, One Guthrie Square, Sayre, PA 18840. E-mail: Williams_carol{at}guthrie.org







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2004 by the American Society for Pharmacology and Experimental Therapeutics